Can We Edit Our Genes to Fight Disease?
Novartis adopts a CRISPR-based system to modify DNA in human cells for patients.
A Boost for Immunotherapy
T cells engineered to recognize cancer help some patients fight the disease. Researchers hope to expand on the experimental treatment with CRISPR-based gene editing.
Team explores gene therapy for hematological disorders.
Neglected Tropical Diseases Take Priority
The Novartis Institutes for Tropical Diseases focuses exclusively on neglected tropical diseases such as dengue fever, malaria, and African sleeping sickness.